Lonza Group AG Market Cap ($37.10 Billion)
Market Cap & Net Worth: Lonza Group AG (LONN)
Lonza Group AG market cap. Lonza Group AG (SW:LONN) has a market capitalization of $37.10 Billion (CHF29.35 Billion) as of October 25, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #725 globally and #11 in its home market, demonstrating a 4.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lonza Group AG's stock price CHF631.80 by its total outstanding shares 69844229 (69.84 Million).
Lonza Group AG Market Cap History (2015–2026)
Lonza Group AG market cap history from 2015 to 2026. Data shows growth from $12.32 Billion to $55.79 Billion (16.42% CAGR). Check latest Lonza Group AG stock price today for real-time trading data and today's change.
Index Memberships
Lonza Group AG is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
STOXX Europe Mid 200 EUR Price
MCXP
|
$1.47 Trillion | 2.52% | #9 of 157 |
|
STOXX Europe Mid 200 EUR Net Return
MCXR
|
$1.47 Trillion | 2.52% | #9 of 157 |
Weight: Lonza Group AG's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Lonza Group AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lonza Group AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Lonza Group AG operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
7.27x
Lonza Group AG's market cap is 7.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $13.52 Billion | $4.13 Billion | $301.00 Million | 3.27x | 44.92x |
| 2017 | $22.11 Billion | $4.55 Billion | $726.00 Million | 4.86x | 30.46x |
| 2018 | $21.61 Billion | $5.54 Billion | $559.00 Million | 3.90x | 38.67x |
| 2019 | $30.24 Billion | $4.21 Billion | $645.00 Million | 7.19x | 46.89x |
| 2020 | $49.02 Billion | $4.51 Billion | $869.00 Million | 10.87x | 56.41x |
| 2021 | $65.97 Billion | $5.41 Billion | $2.94 Billion | 12.20x | 22.41x |
| 2022 | $39.47 Billion | $6.22 Billion | $1.22 Billion | 6.34x | 32.48x |
| 2023 | $30.99 Billion | $6.72 Billion | $654.00 Million | 4.61x | 47.39x |
| 2024 | $47.31 Billion | $5.48 Billion | $636.00 Million | 8.63x | 74.39x |
| 2025 | $47.49 Billion | $6.53 Billion | -$275.00 Million | 7.27x | N/A |
Competitor Companies of LONN by Market Capitalization
Companies near Lonza Group AG in the global market cap rankings as of October 25, 2026. See LONN equity financing ratio to understand what proportion of total assets are financed by equity.
Key companies related to Lonza Group AG by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #142 globally with a market cap of $162.81 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #481 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #524 globally with a market cap of $52.38 Billion USD ( CN¥357.93 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $673.82 |
| #142 | Danaher Corporation | NYSE:DHR | $162.81 Billion | $230.50 |
| #481 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $403.95 |
| #524 | WuXi AppTec Co Ltd | SHG:603259 | $52.38 Billion | CN¥144.72 |
Market Capitalization of Lonza Group AG (2015–2026)
Market capitalization of Lonza Group AG from 2015 to today. Between 2015 and today, Lonza Group AG's market cap moved from $12.32 Billion to $ 55.79 Billion, with a yearly change of 16.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF55.79 Billion | +17.48% |
| 2025 | CHF47.49 Billion | +0.37% |
| 2024 | CHF47.31 Billion | +52.64% |
| 2023 | CHF30.99 Billion | -21.46% |
| 2022 | CHF39.47 Billion | -40.18% |
| 2021 | CHF65.97 Billion | +34.60% |
| 2020 | CHF49.02 Billion | +62.08% |
| 2019 | CHF30.24 Billion | +39.91% |
| 2018 | CHF21.61 Billion | -2.25% |
| 2017 | CHF22.11 Billion | +63.54% |
| 2016 | CHF13.52 Billion | +9.78% |
| 2015 | CHF12.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 25th, 2026 the market cap of Lonza Group AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $37.10 Billion USD |
| MoneyControl | $37.10 Billion USD |
| MarketWatch | $37.10 Billion USD |
| marketcap.company | $37.10 Billion USD |
| Reuters | $37.10 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lonza Group AG
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biol… Read more